A dozen papers have been retracted so far, and six more are planned.

The New York State Psychiatric Institute in New York City is undergoing an audit and a change in leadership following a suicide that occurred during one of its clinical trials.

A total of 17 studies have already been retracted or are slated for retraction over issues with participant consent.

The University of Maryland found the papers included some data without participant consent.

The journal’s decision comes two years after Spectrum covered backlash from researchers over the study.

A renowned researcher’s eye for detail has given her a second career and a new following.

The paper marks the second retraction for one of the co-authors.

The papers were flagged by a method that has now been called into question.

The retracted studies mar hope for the drug’s use in depression.

The paper used more than two dozen such terms, which have cropped up in thousands of published papers in recent years.